Seroprevalence to SARS-CoV-2 in Patients with Rheumatic Diseases on Disease Modifying Antirheumatic Drugs and /or Immunosuppressive Medications from India: A Multicentric Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Seroprevalence to SARS-CoV-2 in Patients with Rheumatic Diseases on Disease Modifying Antirheumatic Drugs and /or Immunosuppressive Medications from India: A Multicentric Study

Published:2022 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Misra Ramnath,Bhattacharya Debdutta,Ahmed Sakir,Amin Sanjiv,Shobha Vineeta,Ghosh Alakendu,Pandya Sapan C,Parai Debaprasad,Padhan Prasanta,Priyadarshini Subhadra,Patro A Raj Kumar,Mohanty Ambika Prasad,Pati Sanghamitra

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference30 articles.

1. First confirmed case of COVID-19 infection in India: A case report;M A Andrews;Indian J Med Res,2020

2. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area;S Richardson;JAMA,2020

3. COVID-19 Global Rheumatology Alliance. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry;A Strangfeld;Ann Rheum Dis,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP